Form 8-K - Current report:
SEC Accession No. 0001326732-24-000052
Filing Date
2024-10-04
Accepted
2024-10-04 08:15:32
Documents
15
Period of Report
2024-09-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xncr-20240930.htm   iXBRL 8-K 25216
2 EX-99.1 xncr-20240930xexx991.htm EX-99.1 4815
6 xencora.jpg GRAPHIC 6197
  Complete submission text file 0001326732-24-000052.txt   163089

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xncr-20240930.xsd EX-101.SCH 1898
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xncr-20240930_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xncr-20240930_pre.xml EX-101.PRE 12506
17 EXTRACTED XBRL INSTANCE DOCUMENT xncr-20240930_htm.xml XML 2728
Mailing Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107
Business Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

EIN.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36182 | Film No.: 241353580
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)